138 related articles for article (PubMed ID: 1925168)
1. Detection of outlying data in bioavailability/bioequivalence studies.
Liu JP; Weng CS
Stat Med; 1991 Sep; 10(9):1375-89. PubMed ID: 1925168
[TBL] [Abstract][Full Text] [Related]
2. Examining outlying subjects and outlying records in bioequivalence trials.
Wang W; Chow SC
J Biopharm Stat; 2003 Feb; 13(1):43-56. PubMed ID: 12635902
[TBL] [Abstract][Full Text] [Related]
3. Outlier detection in bioavailability/bioequivalence studies.
Chow SC; Tse SK
Stat Med; 1990 May; 9(5):549-58. PubMed ID: 2135947
[TBL] [Abstract][Full Text] [Related]
4. The impact of outlying subjects on decision of bioequivalence.
Ki FY; Liu JP; Wang W; Chow SC
J Biopharm Stat; 1995 Mar; 5(1):71-94. PubMed ID: 7613561
[TBL] [Abstract][Full Text] [Related]
5. On population and individual bioequivalence.
Schall R; Luus HG
Stat Med; 1993 Jun; 12(12):1109-24. PubMed ID: 8210816
[TBL] [Abstract][Full Text] [Related]
6. Effect of Different Sampling Schedules on Results of Bioavailability and Bioequivalence Studies: Evaluation by Means of Monte Carlo Simulations.
Kano EK; Chiann C; Fukuda K; Porta V
Drug Res (Stuttg); 2017 Aug; 67(8):451-457. PubMed ID: 28561232
[TBL] [Abstract][Full Text] [Related]
7. Comparing treatment variances in repeated measures bioavailability trials.
Jiang G; Sarkar SK
Stat Med; 1999 May; 18(9):1133-49. PubMed ID: 10378261
[TBL] [Abstract][Full Text] [Related]
8. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.
Gaudreault J; Potvin D; Lavigne J; Lalonde RL
Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507
[TBL] [Abstract][Full Text] [Related]
9. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
Schall R
Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
[TBL] [Abstract][Full Text] [Related]
10. Outlying Observation Diagnostics in Growth Curve Modeling.
Tong X; Zhang Z
Multivariate Behav Res; 2017; 52(6):768-788. PubMed ID: 29161189
[TBL] [Abstract][Full Text] [Related]
11. Use of the repeated cross-over designs in assessing bioequivalence.
Liu JP
Stat Med; 1995 May 15-30; 14(9-10):1067-78; discussion 1079-80. PubMed ID: 7569501
[TBL] [Abstract][Full Text] [Related]
12. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.
Walker SE; Friesen MH
J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658
[TBL] [Abstract][Full Text] [Related]
13. Robust and bootstrap testing procedures for bioequivalence.
Shen CF; Iglewicz B
J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
[TBL] [Abstract][Full Text] [Related]
14. Estimation of direct formulation effect under log-normal distribution in bioavailability/bioequivalence studies.
Liu JP; Weng CS
Stat Med; 1992 May; 11(7):881-96. PubMed ID: 1604068
[TBL] [Abstract][Full Text] [Related]
15. New bioequivalence studies: individual bioequivalence and population bioequivalence.
Nakai K; Fujita M; Ogata H
Yakugaku Zasshi; 2000 Nov; 120(11):1201-8. PubMed ID: 11190205
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
[TBL] [Abstract][Full Text] [Related]
17. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Chen YI; Huang CS
Stat Med; 2014 Feb; 33(5):786-97. PubMed ID: 24105871
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
19. A comparison of four different methods for outlier detection in bioequivalence studies.
Ramsay T; Elkum N
J Biopharm Stat; 2005; 15(1):43-52. PubMed ID: 15702604
[TBL] [Abstract][Full Text] [Related]
20. Fieller's confidence intervals for the ratio of two means in the assessment of average bioequivalence from crossover data.
Vuorinen J; Tuominen J
Stat Med; 1994 Dec 15-30; 13(23-24):2531-45. PubMed ID: 7701152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
